LONDON, Nov. 20, 2017 (GLOBE NEWSWIRE) -- The global diabetes care devices market will grow at a CAGR of 5.3% from 2017 to 2022 to reach USD 26,710.3 million by 2022, according to the latest publication from Meticulous Research™. This market is driven by the increasing incidence & prevalence of diabetes, technological advancements, rising obesity rate, and increasing sedentary lifestyle & improper diet. Moreover, various developments of new technologies for the delivery of insulin further provide significant opportunities in this market. However, high cost associated with the diagnosis and treatment, reimbursement issues, and lack of awareness is expected to hinder the growth of diabetes care devices market to some extent.
The diabetes monitoring devices segment held the largest share of the overall market in 2016 and is expected to continue its dominance during the forecast period, mainly due to the increased adoption of test strips and self-monitoring blood glucose devices across the globe and increasing trend of self-management with rising awareness of the disease in the developing countries.
Request Sample Report: http://www.meticulousresearch.com/request-sam...cp_id=3438
The insulin pens held the largest share of the global insulin delivery devices market in 2016, mainly due to their rising adoption with several advantages over the traditional syringe method of insulin delivery, including improved patient satisfaction and adherence, user-friendliness, superior accuracy for delivering small doses of insulin, greater social acceptability, and less reported injection pain.
The U.S. contributed major share of the global market, primarily due to the large & growing base of diabetic patients, well-established healthcare infrastructure, higher adoption of technologically innovative diabetic care products, increasing research on diabetes, and presence of large number of leading players in this region. However, Asia-Pacific region possesses lucrative growth potential for the diabetes care devices market during the forecast period, owing to the rising diabetic population and increasing complexities associated with the disease on health of the people in the region.
The key players in the global diabetes care devices market are Novo Nordisk A/S, Ypsomed AG, Abbott Laboratories, Ascensia Diabetes Care Holdings AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Medtronic, Becton, Dickinson and Company, Terumo Corporation, and Sanofi AS.
Full News: http://www.meticulousresearch.com/diabetes-ca...es-market/
Scope of the Report
Market by Type
- Diabetes monitoring devices - Test strips - Self-monitoring devices - Continuous blood glucose monitoring devices - Lancets - Haemoglobin A1c testing kits
- Insulin delivery devices - Insulin Pens - Insulin Syringes - Insulin Pumps - Insulin Jet Injectors
Browse in-depth report on http://www.meticulousresearch.com/product/dia...rket-2022/
Contact Info:
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
